MST1 and neoplasm: We utilized a selective MST1/2 inhibitor, XMU‐MP‐1 (XMU), which promotes nuclear localization and activation of YAP.[43] Since YAP has been shown to promote tumor growth and metastasis,[44, 45] we tested the appropriate dose of XMU in brain organoid development.